{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:00:07Z","timestamp":1787162407072,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fujian Provincial Natural Science Foundation of China","award":["2017J01232"],"award-info":[{"award-number":["2017J01232"]}]},{"name":"Fujian Provincial Maternity and Children\u2019s Hospital Technology Innovation Project","award":["YCXM-19-01"],"award-info":[{"award-number":["YCXM-19-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s12032-020-01363-z","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T15:05:03Z","timestamp":1585580703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["HR-HPV viral load quality detection provide more accurate prediction for residual lesions after treatment: a prospective cohort study in patients with high-grade squamous lesions or worse"],"prefix":"10.1007","volume":"37","author":[{"given":"Lihua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5072-6091","authenticated-orcid":false,"given":"Pengming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"1363_CR1","unstructured":"Globocan. Cervical Cancer estimated incidence, mortality and prevalence worldwide in 2012. Available from: https:\/\/globocan.iarc.fr\/old\/FactSheets\/cancers\/cervix-new.asp."},{"issue":"2","key":"1363_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, et al. (2012) Global cancer statistics. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1363_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. (2015) Cancer statistics in China. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1363_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","volume":"121","author":"LS Massad","year":"2013","unstructured":"Massad LS, Einstein MH, Huh WK, et al. 2012 ASCCP Consensus Guidelines Conference 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121(4):829\u201346.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"1363_CR5","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/ijc.21604","volume":"118","author":"WP Soutter","year":"2006","unstructured":"Soutter WP, Sasieni P, Panoskaltsis T. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia. Int J Cancer. 2006;118(8):2048\u201355.","journal-title":"Int J Cancer"},{"issue":"4","key":"1363_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/LGT.0b013e3182454ab4","volume":"16","author":"M Cairns","year":"2012","unstructured":"Cairns M, Tidy J, Cruickshank ME. Management of microinvasive cervical cancer: a British Society for Colposcopy and Cervical Pathology audit. J Low Genit Tract Dis. 2012;16(4):403\u20138.","journal-title":"J Low Genit Tract Dis"},{"key":"1363_CR7","unstructured":"Colposcopy and Programme Management: addendum to NHSCSP Publication No 20 exceptions applicable in NHS Scotland (2013). 2nd ed: NHS Scotland."},{"key":"1363_CR8","volume-title":"NHSCSP Colposcopy and Programme Management","author":"J Tidy","year":"2016","unstructured":"Tidy J. NHSCSP Colposcopy and Programme Management. 3rd ed. London: Public Health England; 2016.","edition":"3"},{"key":"1363_CR9","first-page":"258","volume":"6","author":"M Origoni","year":"2012","unstructured":"Origoni M, Cristoforoni P, Costa S, et al. HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice. Ecancermedicalscience. 2012;6:258.","journal-title":"Ecancermedicalscience"},{"issue":"4","key":"1363_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1586\/14737140.2014.867810","volume":"14","author":"B Sehnal","year":"2014","unstructured":"Sehnal B, Cibula D, Slama J. Factors influencing decisions about surgical treatment of cervical precancerous lesions. Expert Rev Anticancer Ther. 2014;14(4):441\u201351.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1363_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jcv.2018.01.006","volume":"99\u2013100","author":"M Segondy","year":"2018","unstructured":"Segondy M, Ngou J, Kelly H, et al. Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV. J Clin Virol. 2018;99\u2013100:79\u201383.","journal-title":"J Clin Virol"},{"issue":"3","key":"1363_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/jmv.24645","volume":"89","author":"Z Wu","year":"2017","unstructured":"Wu Z, Qin Y, Yu L, et al. Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: Results from a large-scale cross-sectional study. J Med Virol. 2017;89(3):535\u201341.","journal-title":"J Med Virol"},{"issue":"1","key":"1363_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1158\/1055-9965.EPI-12-0953-T","volume":"22","author":"K Sundstrom","year":"2013","unstructured":"Sundstrom K, Ploner A, Dahlstrom LA, et al. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(1):150\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"1363_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/jnci\/djn461","volume":"101","author":"LF Xi","year":"2009","unstructured":"Xi LF, Koutsky LA, Castle PE, et al. Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2\u20133. J Natl Cancer Inst. 2009;101(3):153\u201361.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"1363_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1158\/1055-9965.EPI-09-0838","volume":"19","author":"C Constandinou-Williams","year":"2010","unstructured":"Constandinou-Williams C, Collins SI, Roberts S, et al. Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal study. Cancer Epidemiol Biomarkers Prev. 2010;19(3):832\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1363_CR16","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.2147\/CMAR.S179724","volume":"10","author":"B Dong","year":"2018","unstructured":"Dong B, Sun P, Ruan G, et al. Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case- control study. Cancer Manag Res. 2018;10:4839\u201351.","journal-title":"Cancer Manag Res"},{"issue":"12","key":"1363_CR17","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S1470-2045(17)30700-3","volume":"18","author":"M Arbyn","year":"2017","unstructured":"Arbyn M, Redman CWE, Verdoodt F, et al. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Lancet Oncol. 2017;18(12):1665\u2013799.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1363_CR18","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/ijc.24794","volume":"126","author":"YT Kim","year":"2010","unstructured":"Kim YT, Lee JM, Hur SY, et al. Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Int J Cancer. 2010;126(8):1903\u20139.","journal-title":"Int J Cancer"},{"issue":"3","key":"1363_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ygyno.2005.10.028","volume":"101","author":"SH Song","year":"2006","unstructured":"Song SH, Lee JK, Oh MJ, et al. Persistent HPV infection after conization in patients with negative margins. Gynecol Oncol. 2006;101(3):418\u201322.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"1363_CR20","first-page":"26","volume":"8","author":"I Verma","year":"2014","unstructured":"Verma I, Jain V, Kaur T. Application of bethesda system for cervical cytology in unhealthy cervix. J Clin Diagn Res. 2014;8(9):26\u201330.","journal-title":"J Clin Diagn Res"},{"issue":"5","key":"1363_CR21","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.3802\/jgo.2017.28.e50","volume":"28","author":"P Sun","year":"2017","unstructured":"Sun P, Song Y, Ruan G, et al. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study. J Gynecol Oncol. 2017;28(5):e50.","journal-title":"J Gynecol Oncol"},{"issue":"10","key":"1363_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1055\/s-0035-1558052","volume":"75","author":"O Reich","year":"2015","unstructured":"Reich O, Regauer S, Marth C, et al. Precancerous lesions of the cervix, vulva and vagina according to the 2014 WHO classification of tumors of the female genital tract. Geburtshilfe Frauenheilkd. 2015;75(10):1018\u201320.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"6","key":"1363_CR23","first-page":"541","volume":"24","author":"E Paraskevaidis","year":"2003","unstructured":"Paraskevaidis E, Kalantaridou SN, Paschopoulos M, et al. Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol. 2003;24(6):541\u20133.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"1363_CR24","first-page":"372","volume":"12","author":"ME Sherman","year":"2003","unstructured":"Sherman ME, Wang SS, Tarone R, et al. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias. Cancer Epidemiol Biomarkers Prev. 2003;12(4):372\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"1363_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"MR McCredie","year":"2008","unstructured":"McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425\u201334.","journal-title":"Lancet Oncol"},{"key":"1363_CR26","first-page":"149","volume":"76","author":"AB Miller","year":"1986","unstructured":"Miller AB. Evaluation of the impact of screening for cancer of the cervix. IARC Sci Publ. 1986;76:149\u201360.","journal-title":"IARC Sci Publ"},{"issue":"5","key":"1363_CR27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/bjc.2012.5","volume":"106","author":"M Kocken","year":"2012","unstructured":"Kocken M, Berkhof J, van Kemenade FJ, et al. Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing. Br J Cancer. 2012;106(5):817\u201325.","journal-title":"Br J Cancer"},{"issue":"2","key":"1363_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1525-1438.2006.00404.x","volume":"16","author":"D van Hamont","year":"2006","unstructured":"van Hamont D, van Ham MA, Struik-van der Zanden PH, et al. Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia. Int J Gynecol Cancer. 2006;16(2):615\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1363_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ygyno.2007.05.014","volume":"107","author":"JY Park","year":"2007","unstructured":"Park JY, et al. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer. Gynecol Oncol. 2007;107(1):39\u201344.","journal-title":"Gynecol Oncol"},{"key":"1363_CR30","doi-asserted-by":"publisher","first-page":"k499","DOI":"10.1136\/bmj.k499","volume":"360","author":"K Tainio","year":"2018","unstructured":"Tainio K, Athanasiou A, Tikkinen KAO, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;360:k499.","journal-title":"BMJ"},{"issue":"1","key":"1363_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/GME.0000000000000488","volume":"23","author":"WD Kang","year":"2016","unstructured":"Kang WD, Kim SM. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women. Menopause. 2016;23(1):81\u20136.","journal-title":"Menopause"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-020-01363-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-020-01363-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-020-01363-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T19:48:06Z","timestamp":1617047286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-020-01363-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1363"],"URL":"https:\/\/doi.org\/10.1007\/s12032-020-01363-z","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"19 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compiance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Hospital Ethics Committee (FMCH2017J01232).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All individuals participating in this study provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"37"}}